Notably, LRG1 plasma levels correlate with arterial stiffness and reduced vasodilation in patients with type 2 diabetes, which could therefore perhaps be explained by LRG1 tuning of EC TGFβ signalling [50]. Here, LRG1 is linked to type 2 diabetes mellitus.